Most Recent

image: $280 Million Boost for Disease Genomics

$280 Million Boost for Disease Genomics

By | January 18, 2016

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Owl Be Darned

Owl Be Darned

By | December 4, 2015

Researchers studying city-dwelling birds are learning about which animals are more suited to urban life.

1 Comment

image: A Rainforest Chorus

A Rainforest Chorus

By | December 1, 2015

Researchers measure the health of Papua New Guinea’s forests by analyzing the ecological soundscape.

0 Comments

image: Jungle Field Trip

Jungle Field Trip

By | December 1, 2015

Travel to remote rain forests in Papua New Guinea with researchers from The Nature Conservancy who are working with native people to characterize ecosystems there using sound.

0 Comments

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: Urban Owl-Fitters

Urban Owl-Fitters

By | December 1, 2015

How birds with an innate propensity for living among humans are establishing populations in cities

0 Comments

image: Spiders, Prey Leave DNA

Spiders, Prey Leave DNA

By | November 30, 2015

A study of black widow spiders suggests that the arachnids leave traces of their own genetic material and DNA from prey in their sticky webs.

0 Comments

image: Blood Cell Development Reimagined

Blood Cell Development Reimagined

By | November 9, 2015

A new study is rewriting 50 years of biological dogma by suggesting that mature blood cells develop much more rapidly from stem cells than previously thought.

0 Comments

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

Popular Now

  1. NYU Halts Studies, Suspends Investigator
    The Nutshell NYU Halts Studies, Suspends Investigator

    Experiments conducted at the New York University School of Medicine violated several research standards, according to US Food and Drug Administration investigators.

  2. Exercise-Induced Muscle Factor Promotes Memory
  3. The Meaning of Pupil Dilation
    Daily News The Meaning of Pupil Dilation

    Scientists are using pupil measurements to study a wide range of psychological processes and to get a glimpse into the mind.

  4. Brexit’s Effects on Science